The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase
Mori, Giorgia Orena, Beatrice Silvia Franch, Clara Mitchenall, Lesley A. Godbole, Adwait Anand Rodrigues, Liliana Aguilar-Perez, Clara Zemanova, Julia Huszar, Stanislav Forbak, Martin Lane, Thomas R. Sabbah, Mohamad Deboosere, Nathalie Frita, Rosangela Vandeputte, Alexandre Hoffmann, Eik Russo, Riccardo Connell, Nancy Veilleux, Courtney Jha, Rajiv K. Kumar, Pradeep Freundlich, Joel S. Brodin, Priscille Ainsa, Jose Antonio Nagaraja, Valakunja Maxwell, Anthony Mikusova, Katarina Pasca, Maria Rosalia Ekins, Sean
Tuberculosis (Edinburgh, Scotland), 2018
https://doi.org/10.1016/j.tube.2018.08.004
Eik Hoffmann
Hoffmann Eik
ORCID: 0000-0003-4224-1091
Host-directed therapies offer novel opportunities for the fight against tuberculosis. 10.1016/j.drudis.2017.05.005
Evaluation of Cross-presentation in Bone Marrow-derived Dendritic Cells in vitro and Splenic Dendritic Cells ex vivo Using Antigen-coated Beads. 10.21769/BioProtoc.2015
Patterns, Receptors, and Signals: Regulation of Phagosome Maturation. 10.1016/j.it.2017.03.006
Yolk Sac Macrophages, Fetal Liver, and Adult Monocytes Can Colonize an Empty Niche and Develop into Functional Tissue-Resident Macrophages. 10.1016/j.immuni.2016.02.017
Toll-like Receptor 4 Engagement on Dendritic Cells Restrains Phago-Lysosome Fusion and Promotes Cross-Presentation of Antigens. 10.1016/j.immuni.2015.11.006
Autonomous phagosomal degradation and antigen presentation in dendritic cells. 10.1073/pnas.1203912109
Reactive oxygen species production in the phagosome: impact on antigen presentation in dendritic cells. 10.1089/ars.2012.4557
Comparison of micro- and nanoscale Fe⁺³-containing (Hematite) particles for their toxicological properties in human lung cells in vitro. 10.1093/toxsci/kfs014
Titanium dioxide nanoparticles induce oxidative stress and DNA-adduct formation but not DNA-breakage in human lung cells. 10.1186/1743-8977-6-17
The unfolded-protein-response sensor IRE-1α regulates the function of CD8α+ dendritic cells. 10.1038/ni.2808
Synthesis of the compatible solutes glucosylglycerol and trehalose by salt-stressed cells of Stenotrophomonas strains. 10.1016/j.femsle.2004.12.005
Ezrin promotes actin assembly at the phagosome membrane and regulates phago-lysosomal fusion. 10.1111/j.1600-0854.2011.01158.x
Initial receptor-ligand interactions modulate gene expression and phagosomal properties during both early and late stages of phagocytosis. 10.1016/j.ejcb.2010.04.006
Sphingosine-1-phosphate receptors stimulate macrophage plasma-membrane actin assembly via ADP release, ATP synthesis and P2X7R activation. 10.1242/jcs.034207
Dynamin A, Myosin IB and Abp1 couple phagosome maturation to F-actin binding. 10.1111/j.1600-0854.2011.01296.x
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton 10.15252/embr.201744371
Host-pathogen systems for early drug discovery against tuberculosis. 10.1016/j.mib.2017.11.017
Proteomics of Mycobacterium Infection: Moving towards a Better Understanding of Pathogen-Driven Immunomodulation 10.3389/fimmu.2018.00086
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase 10.1016/j.tube.2018.08.004
Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis 10.1021/acsnano.8b07902
Spatiotemporal changes of the phagosomal proteome in dendritic cells in response to LPS stimulation 10.1074/mcp.RA119.001316
IRG1 controls immunometabolic host response and restricts intracellular Mycobacterium tuberculosis infection 10.1101/761551
Paradoxical Roles of the MAL/Tirap Adaptor in Pathologies 10.3389/fimmu.2020.569127
High-Content Analysis Monitoring Intracellular Trafficking and Replication of Mycobacterium tuberculosis Inside Host Cells 10.1007/978-1-0716-1460-0_29
The UPR sensor IRE1α promotes dendritic cell responses to control Toxoplasma gondii infection 10.15252/embr.201949617
Rajiv Kumar Jha
Jha Rajiv Kumar
ORCID: 0000-0001-7439-1321
A Type IA DNA/RNA Topoisomerase with RNA Hydrolysis Activity Participates in Ribosomal RNA Processing 10.1016/j.jmb.2020.08.012
A multifunctional type IA DNA/RNA topoisomerase with RNA hydrolysis and rRNA processing activities fromMycobacterium smegmatisandMycobacterium tuberculosis 10.1101/2020.07.13.199935
DNA flowerstructure co-localizes with human pathogens in infected macrophages. 10.1093/nar/gkaa341
Conditional down-regulation of GreA impacts expression of rRNA and transcription factors, affecting Mycobacterium smegmatis survival 10.1038/s41598-020-62703-7
NapA (Rv0430), a Novel Nucleoid-Associated Protein that Regulates a Virulence Operon in Mycobacterium tuberculosis in a Supercoiling-Dependent Manner 10.1016/j.jmb.2019.02.029
Physical and functional interaction between nucleoid-associated proteins HU and Lsr2 of Mycobacterium tuberculosis: altered DNA binding and gene regulation 10.1111/mmi.14202
Regulation of the gyr operon of Mycobacterium tuberculosis by overlapping promoters, DNA topology, and reiterative transcription 10.1016/j.bbrc.2018.05.067
Efficacy of β-lactam/β-lactamase inhibitor combination is linked to WhiB4-mediated changes in redox physiology of Mycobacterium tuberculosis. 10.7554/elife.25624
Transcription facilitated genome-wide recruitment of topoisomerase I and DNA gyrase 10.1371/journal.pgen.1006754
Nitric oxide-inducible Fe-S cluster biogenesis enables Mycobacterium tuberculosis to persist in mice 10.1101/2020.08.10.245365
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase. 10.1016/j.tube.2018.08.004
Efficacy of the I2-lactam/I2-lactamase inhibitor combination is linked to WhiB4 mediated changes in redox physiology of Mycobacterium tuberculosis 10.1101/103028
Efficacy of β-lactam/β-lactamase inhibitor combination is linked to WhiB4-mediated changes in redox physiology of Mycobacterium tuberculosis 10.7554/eLife.25624.001
Mycobacterium tuberculosis SufR responds to nitric oxide via its 4Fe–4S cluster and regulates Fe–S cluster biogenesis for persistence in mice 10.1016/j.redox.2021.102062
Priscille Brodin
Brodin Priscille
ORCID: 0000-0003-0991-7344
Email: priscille.brodin@inserm.fr
How can nanoparticles contribute to antituberculosis therapy? 10.1016/j.drudis.2017.01.011
Host-directed therapies offer novel opportunities for the fight against tuberculosis 10.1016/j.drudis.2017.05.005
A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227
A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227 10.3390/toxins9070227.
Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections 10.2217/nnm-2016-0364
Cyclodextrin-based nanocarriers containing a synergic drug combination: a potential formulation for pulmonary administration of antitubercular drugs 10.1016/j.ijpharm.2017.05.030 10.1016/j.ijpharm.2017.05.030.
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism 10.1007/s00401-016-1652-z
Host-directed therapies offer novel opportunities for the fight against tuberculosis 10.1016/j.drudis.2017.05.005 10.1016/j.drudis.2017.05.005.
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria 10.1111/mmi.13535
Impact of pe_ pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis 10.3389/fcimb.2017.00137
LppM impact on the colonization of macrophages by Mycobacterium tuberculosis 10.1111/cmi.12619
Phenotypic assays for Mycobacterium tuberculosis infection 10.1002/cyto.a.23129 10.1002/cyto.a.23129.
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420 10.1126/science.aag1006
A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters 10.1039/c5ob02630j
Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro 10.1007/s00705-016-2771-5
Mycobacterium tuberculosis LppM Displays an Original Structure and Domain Composition Linked to a Dual Localization 10.1016/j.str.2016.07.009
Mycolactone The amazing analgesic mycobacterial toxin 10.1051/medsci/20163202007
STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection 10.1038/srep29297
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 10.1021/cb5007163
Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo 10.1371/journal.ppat.1004650
High content screening in chemical biology: overview and main challenges 10.1051/medsci/20153102016
High-Content Screening Technology Combined with a Human Granuloma Model as a New Approach To Evaluate the Activities of Drugs against Mycobacterium tuberculosis 10.1128/aac.03705-14
Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system 10.1016/j.vaccine.2015.03.083
Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro 10.3389/fmicb.2015.00438
Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action 10.1128/jvi.01473-15
Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assays 10.1007/978-1-4939-2450-9_24
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening 10.3791/51114
Ligand Efficiency Driven Design of New Inhibitors of Mycobacterium tuberculosis Transcriptional Repressor EthR Using Fragment Growing, Merging, and Linking Approaches 10.1021/jm500422b
Mycobacterial Toxin Induces Analgesia in Buruli Ulcer by Targeting the Angiotensin Pathways 10.1016/j.cell.2014.04.040
Potent antiviral activity of Solanum rantonnetii and the isolated compounds against hepatitis C virus in vitro 10.1016/j.jff.2014.09.022
A novel specific edge effect correction method for RNA interference screenings 10.1093/bioinformatics/btr648
Discovery of Novel N-Phenylphenoxyacetamide Derivatives as EthR Inhibitors and Ethionamide Boosters by Combining High-Throughput Screening and Synthesis 10.1021/jm3003779
Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors 10.1021/jm200825u
The Balance of Apoptotic and Necrotic Cell Death in Mycobacterium tuberculosis Infected Macrophages Is Not Dependent on Bacterial Virulence 10.1371/journal.pone.0047573
Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis 10.1371/journal.pone.0026675
Ethionamide Boosters: Synthesis, Biological Activity, and Structure-Activity Relationships of a Series of 1,2,4-Oxadiazole EthR Inhibitors 10.1021/jm200076a
High-content screening in infectious diseases 10.1016/j.cbpa.2011.05.023
Functional characterization of the Mycobacterium tuberculosis serine/threonine kinase PknJ 10.1099/mic.0.038133-0
High Content Phenotypic Cell-Based Visual Screen Identifies Mycobacterium tuberculosis Acyltrehalose-Containing Glycolipids Involved in Phagosome Remodeling 10.1371/journal.ppat.1001100
High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery 10.4155/fmc.10.223
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting 10.1016/j.biomaterials.2009.09.044
Automated High-Throughput siRNA Transfection in Raw 264.7 Macrophages: A Case Study for Optimization Procedure 10.1177/1087057108328762
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 10.1126/science.1171583
High Content Screening Identifies Decaprenyl-Phosphoribose 2 ' Epimerase as a Target for Intracellular Antimycobacterial Inhibitors 10.1371/journal.ppat.1000645
Systematic Genetic Nomenclature for Type VII Secretion Systems 10.1371/journal.ppat.1000507
Control of M-tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP 10.1371/journal.ppat.0040033
Aquatic insects and transmission of Mycobacterium ulcerans 10.1051/medsci/20072367572
ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity 10.1128/jb.00469-07
Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis 10.1371/journal.ppat.0030062
Protection against mycobacterium ulcerans lesion development by exposure to aquatic insect saliva 10.1371/journal.pmed.0040064
Support vector machines for automatic detection of tuberculosis bacteria in confocal microscopy images 10.1109/isbi.2007.356794
Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues 10.1016/j.bmc.2006.12.009
An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis 10.1128/iai.74.4.2128-2137.2006
Benzofuro 3,2-f 1 benzopyrans: A new class of antitubercular agents 10.1016/j.bmc.2006.03.033
Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence 10.1128/iai.74.1.88-98.2006
High frequency of CD4(+) T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection 10.1128/iai.02086-05
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence 10.1128/jb.00631-06
Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis 10.1016/j.tube.2004.09.009
Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity 10.1074/jbc.M503515200
Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics 10.1099/mic.0.27799-0
Proteomic identification of M. tuberculosis protein kinase substrates: PknB recruits GarA, a FHA domain-containing protein, through activation loop-mediated interactions 10.1016/j.jmb.2005.05.049
Tuberculosis: from genome to vaccine 10.1586/14760584.4.4.541
Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RDI immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6 10.1128/iai.72.4.2170-2176.2004
Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens 10.1086/421468
ESAT-6 proteins: protective antigens and virulence factors? 10.1016/j.tim.2004.09.007
Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex 10.1099/mic.0.26662-0
CD8(+)-T-cell responses of mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family 10.1128/iai.71.12.7173-7177.2003
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis 10.1038/nm859
A new evolutionary scenario for the Mycobacterium tuberculosis complex 10.1073/pnas.052548299
Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant 10.1128/iai.70.10.5568-5578.2002
Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides 10.1021/bi015732y
Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti 10.1046/j.1365-2958.2002.03237.x
6-Oxocytidine containing oligonucleotides inhibit the HIV-1 integrase in vitro 10.1081/ncn-100002322
Determinants of Mg2+-dependent activities of recombinant human immunodeficiency virus type 1 integrase 10.1021/bi000398b
Inhibition of the human immunodeficiency virus type 1 DNA integration by modified oligonucleotides 10.1023/a:1026631910681
Branched oligonucleotide-intercalator conjugate forming a parallel stranded structure inhibits HIV-1 integrase 10.1016/s0014-5793(99)01350-2
Inhibition of HIV-1 integration by mono- & bi-functionalized triple helix forming oligonucleotides 10.1080/07328319908044831
Optimization of alternate-strand triple helix formation at the 5 '-TpA-3 ' and 5 '-ApT-3 ' junctions 10.1093/nar/27.15.3029
A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus 10.1074/jbc.272.25.16010
Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids 10.1073/pnas.1707840114
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton 10.15252/embr.201744371
ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton 10.15252/embr.201744371 10.15252/embr.201744371.
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles 10.1038/s41598-017-05453-3
Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis 10.1038/s41598-017-11843-4 10.1038/s41598-017-11843-4.
Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays 10.1021/acschembio.7b00091
Host-pathogen systems for early drug discovery against tuberculosis 10.1016/j.mib.2017.11.017 10.1016/j.mib.2017.11.017.
Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages 10.1016/j.chom.2017.07.020 10.1016/j.chom.2017.07.020. Epub 2017 Aug 31.
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling 10.1016/j.celrep.2017.08.101 10.1016/j.celrep.2017.08.101.
Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids 10.1073/pnas.1707840114 10.1073/pnas.1707840114.
Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry 10.1128/jvi.01982-17
Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors 10.1016/j.celrep.2018.03.125
Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis 10.1016/j.bioorg.2018.08.025
Proteomics of Mycobacterium infection: Moving towards a Better Understanding of Pathogen-Driven immunomodulation 10.3389/fimmu.2018.00086
Synergy between circular bacteriocin AS-48 and ethambutol against Mycobacterium tuberculosis 10.1128/aac.00359-18
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase 10.1016/j.tube.2018.08.004
Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis 10.1038/s41598-017-11843-4
Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs 10.1016/j.ijpharm.2017.05.030
Host-pathogen systems for early drug discovery against tuberculosis 10.1016/j.mib.2017.11.017
Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages 10.1016/j.chom.2017.07.020
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling 10.1016/j.celrep.2017.08.101
Phenotypic assays for Mycobacterium tuberculosis infection 10.1002/cyto.a.23129
A fast, fully automated cell segmentation algorithm for high-throughput and high-content screening 10.1002/cyto.a.20627
Compartmentalized Encapsulation of Two Antibiotics in Porous Nanoparticles: an Efficient Strategy to Treat Intracellular Infections 10.1002/ppsc.201800360
Spatiotemporal Changes of the Phagosomal Proteome in Dendritic Cells in Response to LPS Stimulation 10.1074/mcp.RA119.001316
Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters 10.3389/fphar.2019.00378
Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis 10.1021/acsnano.8b07902
Mitochondrial Dynamics and Activity in Legionella-Infected Cells 10.1007/978-1-4939-9048-1_13
Heparin-Binding Hemagglutinin Adhesin (HBHA) Is Involved in Intracytosolic Lipid Inclusions Formation in Mycobacteria 10.3389/fmicb.2018.02258
Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus, Is a New Inhibitor of Hepatitis C Virus RNA Replication 10.1128/jvi.02009-18
A novel codrug made of the combination of ethionamide and its potentiating booster: synthesis, self-assembly into nanoparticles and antimycobacterial evaluation 10.1039/C9OB00680J
Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls 10.3390/toxins11090516
Paradoxical Roles of the MAL/Tirap Adaptor in Pathologies. 10.3389/fimmu.2020.569127
Fragment-Based Optimized EthR Inhibitors with in Vivo Ethionamide Boosting Activity. 10.1021/acsinfecdis.9b00277
Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds. 10.1371/journal.pone.0227224
Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis. 10.1016/j.vaccine.2019.11.085
IRG1 controls immunometabolic host response and restricts intracellular Mycobacterium tuberculosis infection 10.1101/761551
Worms' Antimicrobial Peptides. 10.3390/md17090512
Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture. 10.1371/journal.pone.0198226
Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. 10.3389/fmicb.2015.00488
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. 10.1038/nm.3262
Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. 10.1021/jm300377g
Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease. 10.1186/1753-6561-5-s1-p38
Automated HTS/HCS for antivirals using visual HIV full replication assays. 10.1186/1742-4690-6-s2-p82
Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. 10.4049/jimmunol.174.6.3570
Cell microbiology interview 10.1111/cmi.13288
Pathogenomic analyses of Mycobacterium microti, an ESX-1-deleted member of the Mycobacterium tuberculosis complex causing disease in various hosts 10.1099/mgen.0.000505
José Antonio Aínsa Claver
Aínsa Claver José Antonio / José Antonio Aínsa
ORCID: 0000-0003-2076-844X
Selective Targeting of Human and Animal Pathogens of the Helicobacter Genus by Flavodoxin Inhibitors: Efficacy, Synergy, Resistance and Mechanistic Studies 10.3390/ijms221810137
Design, synthesis and inhibitory activity against Mycobacterium tuberculosis thymidine monophosphate kinase of acyclic nucleoside analogues with a distal imidazoquinolinone 10.1016/j.ejmech.2010.09.056
Transcriptional analysis of and resistance level conferred by the aminoglycoside acetyltransferase gene aac(2')-Id from Mycobacterium smegmatis. 10.1093/jac/dkm440
Aminoglycoside 2'-N-acetyltransferase genes are universally present in mycobacteria: Characterization of the aac(2')-lc gene from Mycobacterium tuberculosis and the aac(2')-ld gene from Mycobacterium smegmatis 10.1046/j.1365-2958.1997.3471717.x
Construction of a family of Mycobacterium/Escherichia coli shuttle vectors derived from pAL5000 and pACYC184: Their use for cloning an antibiotic-resistance gene from Mycobacterium fortuitum 10.1016/0378-1119(96)00202-8
Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux 10.1038/nm.3458
Analysis of Mutations in Streptomycin-Resistant Strains Reveals a Simple and Reliable Genetic Marker for Identification of the Mycobacterium tuberculosis Beijing Genotype 10.1128/JCM.01944-12
Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in vitro and ex vivo within human macrophages 10.1016/j.jep.2013.01.013
Role of the Mmr Efflux Pump in Drug Resistance in Mycobacterium tuberculosis 10.1128/AAC.01482-12
Mycobacterial Shuttle Vectors Designed for High-Level Protein Expression in Infected Macrophages 10.1128/AEM.01674-12
Functional and Genetic Characterization of the Tap Efflux Pump in Mycobacterium bovis BCG 10.1128/AAC.05946-11
A Prodrug Approach for Improving Antituberculosis Activity of Potent Mycobacterium tuberculosis Type II Dehydroquinase Inhibitors 10.1021/jm2006063
Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique 10.1016/j.jep.2011.04.062
The complex whiJ locus mediates environmentally sensitive repression of development of Streptomyces coelicolor A3(2) 10.1007/s10482-010-9443-3
Role of the Mycobacterium tuberculosis P55 Efflux Pump in Intrinsic Drug Resistance, Oxidative Stress Responses, and Growth 10.1128/AAC.00550-09
Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG 10.1093/jac/dkl510
Novel streptomycin resistance gene from Mycobacterium fortuitum 10.1128/AAC.00223-06
Characterization of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum 10.1093/jac/dki436
Role of mycobacterial efflux transporters in drug resistance: an unresolved question. 10.1111/j.1574-6976.2005.00002.x
Molecular approaches to tuberculosis. 10.1046/j.1365-2958.2001.02652.x
Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis 10.1128/AAC.45.3.800-804.2001
WhiA, a protein of unknown function conserved among gram-positive bacteria, is essential for sporulation in Streptomyces coelicolor A3(2) 10.1128/JB.182.19.5470-5478.2000
A response regulator-like protein that functions at an intermediate stage of sporulation in Streptomyces coelicolor A3(2) 10.1046/j.1365-2958.1999.01630.x
Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs. 10.1586/eri.12.89
Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development 10.1016/j.bcp.2015.05.001
Measuring efflux and permeability in mycobacteria. 10.1007/978-1-4939-2450-9_13
Antituberculosis drugs: reducing efflux = increasing activity 10.1016/j.drudis.2017.01.002
Discovery of antimicrobial compounds targeting bacterial type FAD synthetases 10.1080/14756366.2017.1411910
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase. 10.1016/j.tube.2018.08.004
Total Synthesis of Ripostatin B and Structure-Activity Relationship Studies on Ripostatin Analogs. 10.1021/acs.joc.8b00193
Ionophore A23187 shows anti-tuberculosis activity and synergy with tebipenem. 10.1016/j.tube.2017.09.001
Structure Guided Lead Generation toward Nonchiral M. tuberculosis Thymidylate Kinase Inhibitors. 10.1021/acs.jmedchem.7b01570
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria. 10.1111/mmi.13535
Structure-Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance Contributions. 10.1021/acsinfecdis.6b00158
How can nanoparticles contribute to antituberculosis therapy? 10.1016/j.drudis.2017.01.011
Boldine-Derived Alkaloids Inhibit the Activity of DNA Topoisomerase I and Growth of Mycobacterium tuberculosis. 10.3389/fmicb.2018.01659
Synergy between Circular Bacteriocin AS-48 and Ethambutol against Mycobacterium tuberculosis. 10.1128/aac.00359-18
Inhibition of drug efflux in mycobacteria with phenothiazines and other putative efflux inhibitors. 10.2174/157489111796064579
Isolation by genetic labeling of a new mycobacterial plasmid, pJAZ38, from Mycobacterium fortuitum. 10.1128/jb.179.13.4115-4122.1997
New active formulations against M. tuberculosis: Bedaquiline encapsulation in lipid nanoparticles and chitosan nanocapsules https://doi.org/10.1016/j.cej.2017.12.110
Polypeptidic Micelles Stabilized with Sodium Alginate Enhance the Activity of Encapsulated Bedaquiline 10.1002/mabi.201800397
Co-delivery of free vancomycin and transcription factor decoy-nanostructured lipid carriers can enhance inhibition of methicillin resistant Staphylococcus aureus (MRSA) 10.1371/journal.pone.0220684
In silico discovery and biological validation of ligands of FAD synthase, a promising new antimicrobial target 10.1371/journal.pcbi.1007898
Nanotechnology‐Based Targeted Drug Delivery: An Emerging Tool to Overcome Tuberculosis 10.1002/adtp.202000113
Stanislav Huszar
Huszar Stanislav
ORCID: 0000-0001-7463-1532
DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization 10.1021/acschembio.5b00237
The 8-pyrrole-benzothiazinones are noncovalent inhibitors of DprE1 from Mycobacterium tuberculosis 10.1128/AAC.00778-15
Erratum: Identification of a small molecule with activity against drug-resistant and persistent tuberculosis (Proceedings of the National Academy of Sciences of the United States of America (2013) 27:110 (E2510-E2517)) 10.1073/pnas.1314629110
Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β- d -ribofuranose 2′-Oxidase 10.1021/acs.jmedchem.9b00912
Identification of a small molecule with activity against drug-resistant and persistent tuberculosis 10.1073/pnas.1309171110
A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors 10.1021/acsinfecdis.7b00006
Copper-related toxicity in replicating and dormant Mycobacterium tuberculosis caused by 1-hydroxy-5-R-pyridine-2(1H)-thiones 10.1039/c8mt00067k
The quest for the holy grail: new antitubercular chemical entities, targets and strategies 10.1016/j.drudis.2020.02.003
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase 10.1016/j.tube.2018.08.004
New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action 10.1016/j.ejmech.2018.04.017
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK 10.1038/s41598-018-21614-4
N-acetylglucosamine-1-phosphate transferase, WecA, as a validated drug target in mycobacterium tuberculosis 10.1128/AAC.01310-17
An ABC transporter Wzm–Wzt catalyzes translocation of lipid-linked galactan across the plasma membrane in mycobacteria 10.1073/pnas.2023663118
Giorgia Mori
Mori Giorgia
ORCID: 0000-0003-3469-5632
Pyridine-3,4-dicarboximide as starting material for the total synthesis of the natural product eupolauramine and its isomer iso-eupolauramine endowed with anti-tubercular activities 10.1016/j.tet.2015.01.034
DprE1, a new taxonomic marker in mycobacteria 10.1111/1574-6968.12246
Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth 10.1016/j.ejmech.2015.06.035
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 10.1371/journal.pone.0026675
Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis 10.1016/j.ejmech.2013.10.069
New prodrugs against tuberculosis 10.1016/j.drudis.2016.09.006
Evaluation of the inhibitory activity of (aza)isoindolinone-type compounds: toward in vitro InhA action, Mycobacterium tuberculosis growth and mycolic acid biosynthesis 10.1111/cbdd.12804
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG 10.1016/j.chembiol.2015.05.016
Design, Syntheses, and Anti-TB Activity of 1,3-Benzothiazinone Azide and Click Chemistry Products Inspired by BTZ043 10.1021/acsmedchemlett.5b00424
Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis 10.1021/cb500149m
Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis 10.1016/j.ejmech.2016.07.028
Triazolophthalazines: Easily Accessible Compounds with Potent Antitubercular Activity 10.1002/cmdc.201600085
2-carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1 10.1021/cb5007163
New and old hot drug targets in tuberculosis 10.2174/1389557516666160831164925
A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors 10.1021/acsinfecdis.7b00006
Mechanochemical synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity 10.3390/molecules22091457
Evaluation of heteroatom-rich derivatives as antitubercular agents with InhA inhibition properties 10.1007/s00044-017-2064-x
Shifts of Faecal Microbiota during Sporadic Colorectal Carcinogenesis 10.1038/s41598-018-28671-9
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents 10.1016/j.ejmech.2018.06.033
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase 10.1016/j.tube.2018.08.004
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK 10.1038/s41598-018-21614-4
Synthesis, oxidation potential and anti–mycobacterial activity of isoniazid and analogues: insights into the molecular isoniazid activation mechanism 10.1002/slct.201600040
Gut microbiota analysis in postoperative lynch syndrome patients 10.3389/fmicb.2019.01746
Gut Microbial Signatures in Sporadic and Hereditary Colorectal Cancer 10.3390/ijms22031312
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry. 10.1021/acsmedchemlett.0c00173
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug. 10.3389/fmicb.2020.00292
New Insights into the Mechanism of Action of the Thienopyrimidine Antitubercular Prodrug TP053. 10.1021/acsinfecdis.9b00388
Liliana Rodrigues
Rodrigues Liliana
ORCID: 0000-0002-2094-2666
Measuring efflux and permeability in mycobacteria. 10.1007/978-1-4939-2450-9_13
Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis. 10.1128/aac.01482-12
Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs. 10.1586/eri.12.89
Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis. 10.1371/journal.pone.0034538
Genetic response of Salmonella enterica serotype Enteritidis to thioridazine rendering the organism resistant to the agent. 10.1016/j.ijantimicag.2011.08.013
Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex. 10.1016/j.meegid.2011.08.009
Inhibition of drug efflux in mycobacteria with phenothiazines and other putative efflux inhibitors. 10.2174/157489111796064579
Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance. 10.1186/1471-2180-11-35
Physiological characterisation of the efflux pump system of antibiotic-susceptible and multidrug-resistant Enterobacter aerogenes. 10.1016/j.ijantimicag.2010.06.036
Molecular tools for rapid identification and novel effective therapy against MDRTB/XDRTB infections. 10.1586/eri.10.20
Evaluation of efflux activity of bacteria by a semi-automated fluorometric system. 10.1007/978-1-60327-279-7_12
Fluorometric determination of ethidium bromide efflux kinetics in Escherichia coli. 10.1186/1754-1611-3-18
Identification of nontuberculous mycobacteria in clinical samples using molecular methods: a 3-year study. 10.1111/j.1469-0691.2009.03076.x
The role of efflux pumps in macrolide resistance in Mycobacterium avium complex. 10.1016/j.ijantimicag.2009.07.010
An AcrAB-mediated multidrug-resistant phenotype is maintained following restoration of wild-type activities by efflux pump genes and their regulators. 10.1016/j.ijantimicag.2009.06.029
pH Modulation of efflux pump activity of multi-drug resistant Escherichia coli: protection during its passage and eventual colonization of the colon. 10.1371/journal.pone.0006656
New methods for the identification of efflux mediated MDR bacteria, genetic assessment of regulators and efflux pump constituents, characterization of efflux systems and screening for inhibitors of efflux pumps. 10.2174/138945008785747734
Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. 10.1016/j.ijantimicag.2007.12.015
Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis. 10.1093/jac/dkn070
Antibiotic stress, genetic response and altered permeability of E. coli. 10.1371/journal.pone.0000365
Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis. 10.1128/jcm.43.9.4880-4884.2005
Antituberculosis drugs: reducing efflux=increasing activity. 10.1016/j.drudis.2017.01.002
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria. 10.1111/mmi.13535
Synergy between Circular Bacteriocin AS-48 and Ethambutol against Mycobacterium tuberculosis. 10.1128/aac.00359-18
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase. 10.1016/j.tube.2018.08.004
Boldine-Derived Alkaloids Inhibit the Activity of DNA Topoisomerase I and Growth of Mycobacterium tuberculosis. 10.3389/fmicb.2018.01659
Total Synthesis of Ripostatin B and Structure-Activity Relationship Studies on Ripostatin Analogs. 10.1021/acs.joc.8b00193
Mycobacterial Aminoglycoside Acetyltransferases: A Little of Drug Resistance, and a Lot of Other Roles. 10.3389/fmicb.2019.00046
Design, Synthesis, and Efficacy Testing of Nitroethylene- and 7-Nitrobenzoxadiazol-Based Flavodoxin Inhibitors against Helicobacter pylori Drug-Resistant Clinical Strains and in Helicobacter pylori-Infected Mice 10.1021/acs.jmedchem.9b00355
O contributo dos serviços de diagnóstico laboratorial para o acesso universal à saúde nos países da Comunidade de Língua Portuguesa 10.25761/ANAISIHMT.337
Katarina Mikusova
Mikusova Katarina
ORCID: 0000-0002-0100-4877
Time-adjusted Analysis Shows Weak Associations Between BCG Vaccination Policy and COVID-19 Disease Progression 10.1101/2020.05.01.20087809
Synthesis, docking study and biological evaluation of ᴅ-fructofuranosyl and ᴅ-tagatofuranosyl sulfones as potential inhibitors of the mycobacterial galactan synthesis targeting the galactofuranosyltransferase GlfT2 10.3762/bjoc.16.152
Synthesis of the Arabinose Donor .beta.-D-Arabinofuranosyl-1-monophosphoryldecaprenol, Development of a Basic Arabinosyl-Transferase Assay, and Identification of Ethambutol as an Arabinosyl Transferase Inhibitor 10.1021/ja00153a002
Fragment-Based Design of Mycobacterium tuberculosis InhA Inhibitors 10.1021/acs.jmedchem.0c00007
Development of Macozinone for TB treatment: An Update 10.3390/app10072269
Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents 10.1016/j.ejmech.2020.112773
Biosynthesis of Galactan in Mycobacterium tuberculosis as a Viable TB Drug Target? 10.3390/antibiotics9010020
New Insights into the Mechanism of Action of the Thienopyrimidine Antitubercular Prodrug TP053 10.1021/acsinfecdis.9b00388
Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-d-ribofuranose 2′-Oxidase 10.1021/acs.jmedchem.9b00912
Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents 10.1016/j.chembiol.2019.02.013
New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action 10.1016/j.ejmech.2018.04.017
Copper-related toxicity in replicating and dormantMycobacterium tuberculosiscaused by 1-hydroxy-5-R-pyridine-2(1H)-thiones 10.1039/c8mt00067k
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase 10.1016/j.tube.2018.08.004
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK 10.1038/s41598-018-21614-4
Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria 10.1111/mmi.13535
Learning from the past for TB drug discovery in the future 10.1016/j.drudis.2016.09.025
N-Acetylglucosamine-1-Phosphate Transferase, WecA, as a Validated Drug Target in Mycobacterium tuberculosis 10.1128/aac.01310-17
A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors 10.1021/acsinfecdis.7b00006
Design, Syntheses, and Anti-TB Activity of 1,3-Benzothiazinone Azide and Click Chemistry Products Inspired by BTZ043 10.1021/acsmedchemlett.5b00424
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis 10.1021/acs.jmedchem.5b00608
Assembling of theMycobacterium tuberculosisCell Wall Core 10.1074/jbc.m116.739227
Structural basis for selective recognition of acyl chains by the membrane-associated acyltransferase PatA 10.1038/ncomms10906
Lead selection and characterization of antitubercular compounds using the Nested Chemical Library 10.1016/j.tube.2015.02.028
The Complex Mechanism of Antimycobacterial Action of 5-Fluorouracil 10.1016/j.chembiol.2014.11.006
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG 10.1016/j.chembiol.2015.05.016
The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis 10.1128/aac.00778-15
GtrA Protein Rv3789 Is Required for Arabinosylation of Arabinogalactan in Mycobacterium tuberculosis 10.1128/jb.00628-15
DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization 10.1021/acschembio.5b00237
Purification and characterization of the acyltransferase involved in biosynthesis of the major mycobacterial cell envelope glycolipid – Monoacylated phosphatidylinositol dimannoside 10.1016/j.pep.2014.04.014
DprE1 - from the Discovery to the Promising Tuberculosis Drug Target 10.2174/138161282027140630122724
The Phosphatidyl-myo-Inositol Mannosyltransferase PimA Is Essential for Mycobacterium tuberculosis Growth In Vitro and In Vivo 10.1128/jb.01346-13
AnethA-ethR-Deficient Mycobacterium bovis BCG Mutant Displays Increased Adherence to Mammalian Cells and Greater PersistenceIn Vivo, Which Correlate with Altered Mycolic Acid Composition 10.1128/iai.01332-13
Identification of a small molecule with activity against drug-resistant and persistent tuberculosis 10.1073/pnas.1309171110
Novel synthetic (1 → 6)-α-d-mannodisaccharide substrates support processive mannosylation catalysed by the mycobacterial cell envelope enzyme fraction 10.1039/c3ra43575j
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2′-Oxidase DprE1 10.1021/ja211042r
A Small Multidrug Resistance-like Transporter Involved in the Arabinosylation of Arabinogalactan and Lipoarabinomannan in Mycobacteria 10.1074/jbc.m112.400986
Protein Separation and Enzyme Purification by Preparative Capillary Isotachophoresis 10.1007/s10337-012-2348-8
Synthesis of 1,2,3-Triazolo-Linked Octyl (1→6)-α-d-Oligomannosides and Their Evaluation in Mycobacterial Mannosyltransferase Assay 10.1021/bc100421g
Investigation of ABC transporter from mycobacterial arabinogalactan biosynthetic cluster 10.4149/gpb_2011_03_239
Biosynthetic Origin of the Galactosamine Substituent of Arabinogalactan inMycobacterium tuberculosis 10.1074/jbc.m110.188110
Synthesis of alkyl and cycloalkyl α-d-mannopyranosides and derivatives thereof and their evaluation in the mycobacterial mannosyltransferase assay 10.1016/j.carres.2010.03.011
Synthetic UDP-Furanoses as Potent Inhibitors of Mycobacterial Galactan Biogenesis 10.1016/j.chembiol.2010.10.014
Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance 10.1111/j.1365-2958.2010.07277.x
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 10.1126/science.1171583
Stereoselective syntheses of heptaprenylphosphoryl β-d-arabino-and β-d-ribo-furanoses 10.1016/j.tetlet.2009.02.188
Galactosyl Transferases in Mycobacterial Cell Wall Synthesis 10.1128/jb.01326-07
Identification of promoters recognized by RNA polymerase containing Mycobacterium tuberculosis stress-response sigma factor σF 10.1007/s00203-006-0185-6
Molecular Recognition and Interfacial Catalysis by the Essential Phosphatidylinositol Mannosyltransferase PimA from Mycobacteria 10.1074/jbc.m702087200
Identification of a Novel Galactosyl Transferase Involved in Biosynthesis of the Mycobacterial Cell Wall 10.1128/jb.00489-06
Decaprenylphosphoryl Arabinofuranose, the Donor of the d-Arabinofuranosyl Residues of Mycobacterial Arabinan, Is Formed via a Two-Step Epimerization of Decaprenylphosphoryl Ribose 10.1128/jb.187.23.8020-8025.2005
Polymerization of Mycobacterial Arabinogalactan and Ligation to Peptidoglycan 10.1074/jbc.m302216200
Identification of the Required Acyltransferase Step in the Biosynthesis of the Phosphatidylinositol Mannosides ofMycobacteriumSpecies 10.1074/jbc.m303639200
Definition of the First Mannosylation Step in Phosphatidylinositol Mannoside Synthesis 10.1074/jbc.m204060200
Biosynthesis of the Galactan Component of the Mycobacterial Cell Wall 10.1074/jbc.m006875200
Interaction of Human Mannose‐Binding Protein withMycobacterium avium 10.1086/520354
Hydride-induced Meisenheimer complex formation reflects activity of nitro aromatic anti-tuberculosis compounds 10.1039/D0MD00390E
Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity 10.1021/acsinfecdis.0c00622
An ABC transporter Wzm-Wzt catalyzes translocation of lipid-linked galactan across the plasma membrane in mycobacteria. 10.1073/pnas.2023663118
Lesley Mitchenall
Mitchenall Lesley
ORCID: 0000-0002-0063-1991
Single-molecule imaging of DNA gyrase activity in living Escherichia coli. 10.1093/nar/gky1143
Combining high-resolution AFM with MD simulations shows that DNA supercoiling induces kinks and defects that enhance flexibility and recognition 10.1101/863423
Single-molecule imaging of DNA gyrase activity in living Escherichia coli 10.1101/460006
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase. 10.1016/j.tube.2018.08.004
Negative supercoiling of DNA by gyrase is inhibited in Salmonella enterica serovar Typhimurium during adaptation to acid stress. 10.1111/mmi.13911
A rapid high-resolution method for resolving DNA topoisomers. 10.1186/s13104-018-3147-6
Quinolone-resistant gyrase mutants demonstrate decreased susceptibility to triclosan. 10.1093/jac/dkx201
DNA Gyrase Is the Target for the Quinolone Drug Ciprofloxacin in Arabidopsis thaliana. 10.1074/jbc.M115.689554
DNA G-segment bending is not the sole determinant of topology simplification by type II DNA topoisomerases. 10.1038/srep06158
Application of a novel microtitre plate-based assay for the discovery of new inhibitors of DNA gyrase and DNA topoisomerase VI. 10.1371/journal.pone.0058010
The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action. 10.1074/jbc.M112.419069
A common origin for the bacterial toxin-antitoxin systems parD and ccd, suggested by analyses of toxin/target and toxin/antitoxin interactions. 10.1371/journal.pone.0046499
The role of Ca²⁺ in the activity of Mycobacterium tuberculosis DNA gyrase. 10.1093/nar/gks704
The dimer state of GyrB is an active form: implications for the initial complex assembly and processive strand passage. 10.1093/nar/gkr553
Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics. 10.1093/jac/dkr247
Use of divalent metal ions in the DNA cleavage reaction of topoisomerase IV. 10.1093/nar/gkr018
Vibrio cholerae ParE2 poisons DNA gyrase via a mechanism distinct from other gyrase inhibitors. 10.1074/jbc.M110.138776
Structural and biochemical analysis of the pentapeptide repeat protein EfsQnr, a potent DNA gyrase inhibitor. 10.1128/AAC.01158-10
A crystal structure of the bifunctional antibiotic simocyclinone D8, bound to DNA gyrase. 10.1126/science.1179123
Mapping simocyclinone D8 interaction with DNA gyrase: evidence for a new binding site on GyrB. 10.1128/AAC.00972-09
Crystallization and preliminary X-ray analysis of a complex formed between the antibiotic simocyclinone D8 and the DNA breakage-reunion domain of Escherichia coli DNA gyrase. 10.1107/S1744309109028097
How do type II topoisomerases use ATP hydrolysis to simplify DNA topology beyond equilibrium? Investigating the relaxation reaction of nonsupercoiling type II topoisomerases. 10.1016/j.jmb.2008.11.056
DNA gyrase requires DNA for effective two-site coordination of divalent metal ions: further insight into the mechanism of enzyme action. 10.1021/bi800480j
Hot-spot consensus of fluoroquinolone-mediated DNA cleavage by Gram-negative and Gram-positive type II DNA topoisomerases. 10.1093/nar/gkm653
A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA. 10.1126/science.1110699
Arabidopsis thaliana DNA gyrase is targeted to chloroplasts and mitochondria. 10.1073/pnas.0400836101
Two crystal structures of the cytoplasmic molybdate-binding protein ModG suggest a novel cooperative binding mechanism and provide insights into ligand-binding specificity. 10.1006/jmbi.2001.4636
Extended X-ray absorption fine structure studies on periplasmic and intracellular molybdenum-binding proteins. 10.1007/s007750050381
Crystallization and preliminary X-ray studies on the molbindin ModG from Azotobacter vinelandii. 10.1107/s0907444999005375
Ligand size is a major determinant of specificity in periplasmic oxyanion-binding proteins: the 1.2 A resolution crystal structure of Azotobacter vinelandii ModA. 10.1016/s0969-2126(98)00151-8
Regulation of the transcriptional activators AnfA and VnfA by metals and ammonium in Azotobacter vinelandii. 10.1111/j.1574-6968.1998.tb13068.x
The modE gene product mediates molybdenum-dependent expression of genes for the high-affinity molybdate transporter and modG in Azotobacter vinelandii. 10.1099/13500872-142-8-1997
Mutational analysis of genes of the mod locus involved in molybdenum transport, homeostasis, and processing in Azotobacter vinelandii. 10.1128/jb.177.18.5294-5302.1995
Molybdenum-independent nitrogenases of Azotobacter vinelandii: a functional species of alternative nitrogenase-3 isolated from a molybdenum-tolerant strain contains an iron-molybdenum cofactor. 10.1042/bj2930101
Characterization of genes involved in molybdenum transport in Azotobacter vinelandii. 10.1111/j.1365-2958.1993.tb01136.x
Nucleotide sequences and mutational analysis of the structural genes for nitrogenase 2 of Azotobacter vinelandii. 10.1128/jb.172.6.3400-3408.1990
The function of isolated domains and chimaeric proteins constructed from the transcriptional activators NifA and NtrC of Klebsiella pneumoniae. 10.1111/j.1365-2958.1990.tb02012.x
Genetic evidence for an Azotobacter vinelandii nitrogenase lacking molybdenum and vanadium. 10.1128/jb.171.1.124-129.1989
Positional requirements for the function of nif-specific upstream activator sequences. 10.1007/bf00337770
The pentapeptide-repeat protein, MfpA, interacts with mycobacterial DNA gyrase as a DNA T-segment mimic 10.1073/pnas.2016705118
Summary of the Sussex-Huawei locomotion-transportation recognition challenge
Observation of a manifold in the chaotic phase space of an asymmetric optical microcavity
Localized temporal variation of Earth's inner-core boundary from high-quality waveform doublets
Off-axis multi-wavelength dispersion controlling metalens for multi-color imaging
Impact of United States political sanctions on international collaborations and research in Iran